Inventor
KANDIMALLA EKAMBAR R
US48 patents
⚠️ This page may combine multiple inventors who share the name “KANDIMALLA EKAMBAR R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IDERA PHARMACEUTICALS INC
34 patentsUS7276489B2Oct 2, 2007
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
IDERA PHARMACEUTICALS INC221 citations99
US7812000B2Oct 12, 2010
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
IDERA PHARMACEUTICALS INC66 citations98
US7517862B2Apr 14, 2009
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
IDERA PHARMACEUTICALS INC64 citations98
US7407944B2Aug 5, 2008
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
IDERA PHARMACEUTICALS INC56 citations98
US7262286B2Aug 28, 2007
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
IDERA PHARMACEUTICALS INC42 citations96
US7851453B2Dec 14, 2010
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
IDERA PHARMACEUTICALS INC17 citations93
US7749975B2Jul 6, 2010
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
IDERA PHARMACEUTICALS INC9 citations93
US7709617B2May 4, 2010
Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy
IDERA PHARMACEUTICALS INC18 citations93
US7569554B2Aug 4, 2009
Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents
IDERA PHARMACEUTICALS INC23 citations93
US7354907B2Apr 8, 2008
Short immunomodulatory oligonucleotides
IDERA PHARMACEUTICALS INC38 citations93
US7176296B2Feb 13, 2007
Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
IDERA PHARMACEUTICALS INC52 citations93
US7105495B2Sep 12, 2006
Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
IDERA PHARMACEUTICALS INC48 citations93
US9453228B2Sep 27, 2016
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
IDERA PHARMACEUTICALS INC21 citations92
US8361986B2Jan 29, 2013
Synthetic agonists of TLR9
IDERA PHARMACEUTICALS INC18 citations92
US8008267B2Aug 30, 2011
Stabilized immunomodulatory oligonucleotides
IDERA PHARMACEUTICALS INC29 citations92
US9260719B2Feb 16, 2016
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
IDERA PHARMACEUTICALS INC8 citations84
US9206430B2Dec 8, 2015
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
IDERA PHARMACEUTICALS INC7 citations84
US9096858B2Aug 4, 2015
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
IDERA PHARMACEUTICALS INC8 citations84
US8377898B2Feb 19, 2013
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
IDERA PHARMACEUTICALS INC15 citations84
US8357665B2Jan 22, 2013
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
IDERA PHARMACEUTICALS INC10 citations84
US8030462B2Oct 4, 2011
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
IDERA PHARMACEUTICALS INC8 citations84
US7932367B2Apr 26, 2011
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
IDERA PHARMACEUTICALS INC7 citations84
US7875594B2Jan 25, 2011
Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents
IDERA PHARMACEUTICALS INC11 citations84
US9243050B2Jan 26, 2016
Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
IDERA PHARMACEUTICALS INC7 citations83
US7786089B2Aug 31, 2010
Immunostimulatory activity of immune modulatory oligonucleotides (IMO™) containing different lengths of palindromic segments
IDERA PHARMACEUTICALS INC14 citations83
US7713535B2May 11, 2010
Modulation of immunostimulatory properties by small oligonucleotide-based compounds
IDERA PHARMACEUTICALS INC13 citations83
US7833538B2Nov 16, 2010
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
IDERA PHARMACEUTICALS INC6 citations74
US7824696B2Nov 2, 2010
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
IDERA PHARMACEUTICALS INC6 citations74
US7790168B2Sep 7, 2010
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
IDERA PHARMACEUTICALS INC6 citations74
US9540651B2Jan 10, 2017
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
IDERA PHARMACEUTICALS INC2 citations73
US8362233B2Jan 29, 2013
Stabilized immune modulatory RNA (SIMRA) compounds
IDERA PHARMACEUTICALS INC5 citations73
US10066230B2Sep 4, 2018
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
IDERA PHARMACEUTICALS INC0 citations52
US10041076B2Aug 7, 2018
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
IDERA PHARMACEUTICALS INC0 citations52
US7671035B2Mar 2, 2010
Epidermal growth factor receptor antisense oligonucleotides
IDERA PHARMACEUTICALS INC0 citations52
KANDIMALLA EKAMBAR R
6 patentsUS8476416B2Jul 2, 2013
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
KANDIMALLA EKAMBAR R6 citations84
US8486908B2Jul 16, 2013
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
KANDIMALLA EKAMBAR R11 citations83
US8106173B2Jan 31, 2012
Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
KANDIMALLA EKAMBAR R9 citations83
US8946175B1Feb 3, 2015
Stabilized immunomodulatory oligonucleotides
KANDIMALLA EKAMBAR R5 citations72
US8759310B2Jun 24, 2014
Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
KANDIMALLA EKAMBAR R4 citations72
US8716253B2May 6, 2014
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
KANDIMALLA EKAMBAR R1 citations62
HYBRIDON INC
5 patentsUS6383752B1May 7, 2002
Pseudo-cyclic oligonucleobases
HYBRIDON INC200 citations99
US5886165AMar 23, 1999
Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments
HYBRIDON INC206 citations99
US5912332AJun 15, 1999
Affinity-based purification of oligonucleotides using soluble multimeric oligonucleotides
HYBRIDON INC140 citations98
US5739308AApr 14, 1998
Integrated oligonucleotides
HYBRIDON INC106 citations98
US6372427B1Apr 16, 2002
Cooperative oligonucleotides
HYBRIDON INC46 citations93
AGRAWAL SUDHIR
2 patentsUS8202850B2Jun 19, 2012
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
AGRAWAL SUDHIR60 citations97
US8153608B2Apr 10, 2012
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
AGRAWAL SUDHIR9 citations84